- Home
- IMCR vs CUBI Comparison
IMCR vs CUBI Comparison
Compare IMCR & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- CUBI
- Stock Information
- Founded
- IMCR 2008
- CUBI 1994
- Country
- IMCR United Kingdom
- CUBI United States
- Employees
- IMCR N/A
- CUBI N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- CUBI Major Banks
- Sector
- IMCR Health Care
- CUBI Finance
- Exchange
- IMCR Nasdaq
- CUBI Nasdaq
- Market Cap
- IMCR 1.7B
- CUBI 1.4B
- IPO Year
- IMCR 2021
- CUBI 2012
- Fundamental
- Price
- IMCR $32.93
- CUBI $46.46
- Analyst Decision
- IMCR Buy
- CUBI Buy
- Analyst Count
- IMCR 14
- CUBI 8
- Target Price
- IMCR $74.75
- CUBI $63.86
- AVG Volume (30 Days)
- IMCR 267.8K
- CUBI 290.2K
- Earning Date
- IMCR 11-05-2024
- CUBI 10-31-2024
- Dividend Yield
- IMCR N/A
- CUBI N/A
- EPS Growth
- IMCR N/A
- CUBI 33.08
- EPS
- IMCR N/A
- CUBI 7.41
- Revenue
- IMCR $280,914,000.00
- CUBI $722,462,000.00
- Revenue This Year
- IMCR $25.60
- CUBI N/A
- Revenue Next Year
- IMCR $10.63
- CUBI $11.71
- P/E Ratio
- IMCR N/A
- CUBI $6.12
- Revenue Growth
- IMCR 27.95
- CUBI 25.87
- 52 Week Low
- IMCR $29.72
- CUBI $38.69
- 52 Week High
- IMCR $76.98
- CUBI $68.49
- Technical
- Relative Strength Index (RSI)
- IMCR 52.76
- CUBI 48.18
- Support Level
- IMCR $31.10
- CUBI $44.31
- Resistance Level
- IMCR $35.47
- CUBI $47.11
- Average True Range (ATR)
- IMCR 1.49
- CUBI 1.57
- MACD
- IMCR 0.17
- CUBI 0.05
- Stochastic Oscillator
- IMCR 51.98
- CUBI 28.96
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources, and Financial Products and Services. The majority of revenue is derived from commercial lending.